# Shinji Ohno

Source: https://onco.cc/people/ohno-shinji/  
OnCo record `ohno-shinji` (Person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A senior breast cancer specialist who has led Japanese arms of adjuvant and metastatic breast cancer trials for two decades.

## Summary

Shinji Ohno is Director of the Breast Oncology Center at the Cancer Institute Hospital of JFCR in Tokyo. A senior breast cancer specialist, he has led Japanese arms of adjuvant and metastatic breast cancer trials for two decades, serving as an investigator on CDK4/6, HER2 and adjuvant endocrine trials with Japanese cohorts. His publications include the ESMO Clinical Practice Guidelines for early and primary breast cancer and a machine learning study predicting disease-free survival and brain metastasis in HER2-positive patients treated with neoadjuvant chemotherapy plus trastuzumab. His interests are breast cancer, adjuvant therapy and clinical trials.

## Fields

- Kind: Person
- Last checked: 2026-09-08
- Role: Director, Breast Oncology Center, Cancer Institute Hospital of JFCR
- Specialisms: Breast cancer; Adjuvant therapy; Clinical trials

## Sources

- Cancer Institute Hospital of JFCR: https://www.jfcr.or.jp/english/
- PubMed author search: https://pubmed.ncbi.nlm.nih.gov/?term=Ohno%20S%5BAuthor%5D%20breast%20cancer%20Cancer%20Institute%20Hospital

## Connected records

- cancers: [HER2-positive breast cancer](https://onco.cc/cancers/breast-her2-positive/), [HR-positive / HER2-negative breast cancer](https://onco.cc/cancers/breast-hr-positive/)
- institutions: [Cancer Institute Hospital of JFCR](https://onco.cc/institutions/jfcr/)
- journals: [Breast cancer research and treatment](https://onco.cc/journals/breast-cancer-research-and-treatment/)

---
JSON: https://onco.cc/api/v1/entities/ohno-shinji.json